Literature DB >> 27327291

Spectral-Domain Optical Coherence Tomography Findings in Lipemia Retinalis.

Banu Turgut Özturk, Banu Bozkurt, Ali Meşen, Saban Gonul, Süleyman Hilmi İpekci.   

Abstract

Severe hypertriglyceridemia can give rise to a fundus appearance with whitish-colored retinal vessels called lipemia retinalis. A 52-year-old man with hypertriglyceridemia presented with a best-corrected visual acuity of 20/20 in both eyes and creamy-white retinal vessels on fundus. Spectral-domain optical coherence tomography (SD-OCT) revealed hyperreflective and engorged retinal vessels and white dots mainly accumulated in the inner nuclear and ganglion cell layer. Follow-up fundus examination after plasmapheresis sessions revealed normal retinal vessels. The hyperreflective appearance of the retinal vessels in OCT reversed rapidly 5 days after the treatment, whereas hyperreflective dots in retina disappeared slowly in 3 months. OCT is useful in demonstrating inner retinal changes associated with lipemia retinalis at histopathological level. The hyperreflective dots in inner retina associated with leakage from superficial retinal capillaries attested the correlation of their location with their origin. [Ophthalmic Surg Lasers Imaging Retina. 2016;47:589-592.]. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27327291     DOI: 10.3928/23258160-20160601-13

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  2 in total

1.  Alterations in ocular microcirculation and oxygen metabolism in patients with lipemia retinalis.

Authors:  Waleed K Alsarhani; Fadwa F Al Adel; Abdullah Alamri; Rahaf M Al Malawi; Abdulrahman F AlBloushi
Journal:  BMC Ophthalmol       Date:  2022-07-06       Impact factor: 2.086

2.  Multimodal imaging study of lipemia retinalis with diabetic retinopathy: A case report.

Authors:  Sheng-Juan Zhang; Zhong-Yang Yan; Li-Fei Yuan; Yan-Hui Wang; Li-Fei Wang
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.